Trial Profile
A randomized, open-label, single dose, crossover study to investigate the effect of food on the pharmacokinetics of JLP-1310 in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Metformin/rosuvastatin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 15 Jun 2018 New trial record